FREELINE THERAPEUTICS HLDGS's ticker is FRLN and the CUSIP is 35655L107. A total of 1 filers reported holding FREELINE THERAPEUTICS HLDGS in Q2 2023. The put-call ratio across all filers is - and the average weighting 5.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,163,215 | -25.9% | 4,702,641 | -20.6% | 0.04% | -31.0% |
| Q4 2022 | $2,917,370 | -28.7% | 5,920,765 | -0.5% | 0.06% | -27.5% |
| Q3 2022 | $4,091,000 | -20.8% | 5,950,000 | 0.0% | 0.08% | -27.9% |
| Q2 2022 | $5,168,000 | +30.2% | 5,950,000 | +65.0% | 0.11% | +79.0% |
| Q1 2022 | $3,970,000 | -41.2% | 3,606,192 | +3.5% | 0.06% | -27.9% |
| Q4 2021 | $6,746,000 | -42.7% | 3,485,656 | 0.0% | 0.09% | -44.5% |
| Q3 2021 | $11,779,000 | -40.4% | 3,485,656 | +40.2% | 0.16% | -41.5% |
| Q2 2021 | $19,757,000 | -33.7% | 2,485,656 | 0.0% | 0.26% | -40.0% |
| Q1 2021 | $29,818,000 | -32.6% | 2,485,656 | 0.0% | 0.44% | -34.9% |
| Q4 2020 | $44,266,000 | +24.3% | 2,485,656 | +6.1% | 0.68% | -2.6% |
| Q3 2020 | $35,620,000 | – | 2,343,304 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 1,466,508 | $3,783,591 | 5.70% |